Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia

Photodiagnosis and Photodynamic Therapy

Volumn 11, Issue 1, 2014, Pages 34-40

  Pietruska, Małgorzata ^a,b   Sobaniec, Stefan ^a   Bernaczyk, Piotr ^a   Cholewa, Magdalena ^a   Pietruski, Jan Krzysztof ^a   Dolińska, Ewa ^a   Skurska, Anna ^a   Duraj, Ewa ^a   Tokajuk, Grazyna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Dental Practice   (Poland)

Author keywords

Oral leukoplakia; Photodynamic therapy

Indexed keywords

CHLORIN E6; CHLORINE DERIVATIVE; DIMETHYL SULFOXIDE; PHOTOLON; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; PORPHYRIN; RADIOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DESQUAMATION; DIODE LASER; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; ILLUMINATION; LEUKOPLAKIA; MALE; MOUTH LESION; MOUTH MUCOSA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; CLINICAL TRIAL; LEUKOPLAKIA, ORAL; LOW LEVEL LASER THERAPY; MIDDLE AGED; PROCEDURES;

ADULT; DIMETHYL SULFOXIDE; FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS, SEMICONDUCTOR; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; PORPHYRINS; RADIATION-SENSITIZING AGENTS;

EID: 84895921708     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2013.10.003     Document Type: Article

References (29)

1. Ribeiro A.S., Salles P.R., da Silva T.A., Mesquita R.A. Review of the nonsurgical treatment of oral leukoplakia. Int J Dent 2010, 23:1-10.
2. Grajewski S., Groneberg D. Leukoplakia and erythroplakia - two orale precursor lesions. Laryngorhinootologie 2009, 88:666-672.
3. Reichart P.A., Philipsen H.P. Oral erythroplakia - a review. Oral Oncol 2005, 41:551-561.
4. Zain R.B., Ikeda N., Razak I.A., Axéll T., Majid Z.A., Gupta P.C., et al. A national epidemiological survey of oral mucosal lesions in Malaysia. Community Dent Oral Epidemiol 1997, 25:377-383.
5. Lan A.X., Guan X.B., Sun Z. Analysis of risk factors for carcinogenesis of oral leukoplakia. Zhonghua Kou Qiang Yi Xue Za Zhi 2009, 44:327-331.
6. Napier S.S., Speight P.M. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008, 37:1-10.
7. Hairston B.R., Bruce A.J., Rogers R.S. Viral diseases of the oral mucosa. Dermatol Clin 2003, 21:17-32.
8. Suter V.G., Morger R., Altermatt H.J., Spieler P., Bornstein M.M. Oral erythroplakia and erythroleukoplakia: red and red-white dysplastic lesions of the oral mucosa-part 2: cytodiagnosis, pathogenesis, therapy, and prognostic aspects. Schweiz Monatsschr Zahnmed 2008, 118:510-518.
9. Yeh C.J. Simple cryosurgical treatment for oral lesions. Int J Oral Maxillofac Surg 2000, 29:212-216.
10. Strauss W.S., Sailer R., Schneckenburger H., Akgun N., Gottfried V., Chetwer L., et al. Photodynamic efficacy of naturally occurring porphyrins in endothelial cells in vitro and microvasculature in vivo. J Photochem Photobiol B 1997, 39:176-184.
11. Sibani S.A., McCarron P.A., Woolfson A.D., Donnelly R.F. Photosensitiser delivery for photodynamic therapy, part 2: systemic carrier platforms. Expert Opin Drug Deliv 2008, 5:1241-1254.
12. Juzeniene A. Chlorin e6-based photosensitizers for photodynamic therapy and photodiagnosis. Photodiagn Photodyn Ther 2009, 6:94-96.
13. 2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral Oncol 2005, 41:31-37.
14. Yang S.W., Tsai C.N., Lee Y.S., Chen T.A. Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser-emphasis on the factors affecting recurrence. J Oral Maxillofac Surg 2011, 69:78-87.
15. Ishii J., Fujita K., Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol 2003, 39:759-769.
16. Wildeman M.A., Nyst H.J., Karakullukcu B., Tan B.I. Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer. Head Neck Oncol 2009, 1:40.
17. Biel M.A. Photodynamic therapy in head and neck cancer. Curr Oncol Rep 2002, 4:87-96.
18. Grant W.E., Speight P.M., Hopper C., Bown S.G. Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Int J Cancer 1997, 71:937-942.
19. Kubler A.C., Haase T., Staff C., Kahle B., Rheinwald M., Muhling J. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg Med 1999, 25:60-68.
20. Kubler A., Haase T., Rheinwald M., Barth T., Muhling J. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg 1998, 27:466-469.
21. Chen H.M., Chen C.T., Yang H., Kuo M.Y., Kuo Y.S., Lan W.H., et al. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Oral Oncol 2004, 40:630-637.
22. Sieroń A., Namyslowski G., Misiolek M., Adamek M., Kawczyk-Krupka A. Photodynamic therapy of premalignant lesions and local recurrence of laryngeal and hypopharyngeal cancers. Eur Arch Oto-Rhino-Laryngol 2001, 258:349-352.
23. Sieroń A., Adamek M., Kawczyk-Krupka A., Mazur S., Ilewicz L. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med 2003, 32:330-336.
24. Tsai J.C., Chiang C.P., Chen H.M., Huang S.B., Wang C.W., Lee M.I., et al. Photodynamic therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med 2004, 34:18-24.
25. Shafirstein G., Friedman A., Siegel E., Moreno M., Bäumler W., Fan Ch.Y., et al. Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia. Arch Otolaryngol Head Neck Surg 2011, 137:1117-1123.
26. Chen H.M., Yu C.H., Tu P.C., Yeh C.Y., Tsai T., Chiang C.P. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med 2005, 37:114-122.
27. Grant W.E., Hopper C., Speight P.M., Macrobert A.J., Bown S.G. Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. J Laryngol Otol 1993, 107:1140-1145.
28. Detty M.R., Gibson S.L., Wagner SJ: Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 2004, 47:3897-3915.
29. Ali-Seyed M., Bhuvaneswari R., Soo K.C., Olivo M. Photolon™ - photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes. Int J Oncol 2011, 39:821-831.